Hollencrest Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Hold |
625
| – | – | ﹤0.01% | 575 |
|
|
2025
Q1 | $21.3K | Hold |
625
| – | – | ﹤0.01% | 638 |
|
|
2024
Q4 | $24.6K | Hold |
625
| – | – | ﹤0.01% | 612 |
|
|
2024
Q3 | $29.4K | Hold |
625
| – | – | ﹤0.01% | 586 |
|
|
2024
Q2 | $33.8K | Hold |
625
| – | – | ﹤0.01% | 555 |
|
|
2024
Q1 | $42.6K | Hold |
625
| – | – | ﹤0.01% | 511 |
|
|
2023
Q4 | $39.1K | Hold |
625
| – | – | ﹤0.01% | 521 |
|
|
2023
Q3 | $28.4K | Hold |
625
| – | – | ﹤0.01% | 561 |
|
|
2023
Q2 | $35.1K | Hold |
625
| – | – | ﹤0.01% | 548 |
|
|
2023
Q1 | $28.3K | Hold |
625
| – | – | ﹤0.01% | 570 |
|
|
2022
Q4 | $25.4K | Buy |
+625
| New | +$25.4K | ﹤0.01% | 563 |
|